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The major route to the emergence of new viral pathogens occurs when viruses jump from their 
original hosts to new host species, which is usually followed by intense rounds of virus-host 
adaptation. Over the past century, several viruses with pathogenic properties have entered the 
human population, including human immunodeficiency virus type 1 (HIV-1), severe acute respiratory 
syndrome coronavirus (SARS-CoV) and several assortments of influenza A. For example, HIV-1 and 
HIV-2 arose from a number of cross-species transmissions of simian immunodeficiency viruses 
(SIVs), which naturally infect nonhuman primates in Africa. Studies of the co-evolution of host 
defenses and their viral antagonists are critical to understanding the origins of new pathogenic 
viruses, as well as the susceptibilities of our innate antiviral defenses to these novel threats. 
Host restriction factors impose species-specific barriers to viral replication. One such factor, the 
cytidine deaminase APOBEC3G (A3G), inhibits HIV-1 and related lentiviruses by mutating viral 
nucleic acids. Viral countermeasures include ‘viral infectivity factor’ (Vif), which triggers the 
ubiquitination and proteasomal degradation of A3G. In a recent study, principal investigator Dr. 
Michael Emerman (Human Biology Division), his graduate student, Alex Compton, and an outside 
collaborator at the NIH examined the co-evolutionary dynamics of the A3G-Vif interaction in four 
African green monkey (AGM) species. Next to humans, AGMs are the most abundant primates in 
Africa. Natural variation in SIV infections among AGMs offers a unique opportunity to study how the 
evolution of lentiviruses and the evolution of host antiviral genes influence one another. 
Compton et al. surveyed the degree of A3G genetic diversity in AGMs and found 28 single 
nucleotide polymorphisms (SNPs) that each cause an amino acid replacement, but only a single 
‘synonymous’ SNP that results in no change to the protein. Two of the amino acid-altering 
polymorphisms affect a motif critical to the interaction between Vif and A3G. The authors used 
infectivity assays to show that amino acid substitutions in A3G in two AGM species (grivet and 
sabaeus monkeys) confer resistance to Vif proteins from several SIV strains not normally infecting 
grivet or sabaeus hosts. SIV lineages that do naturally infect these two AGM species have co-
evolved to overcome their novel A3G polymorphisms. To gain insights into the timeframe of viral 
adaptation to host switching, Emerman’s team then investigated samples collected from a prior  
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experimental evolution study, in which sabaeus monkeys were infected with a vervet strain of SIV 
and monitored for almost 2 years. The researchers found that the Vif proteins of the viruses rapidly 
evolved specificity of antagonism with respect to the A3G genotypes of the sabaeus monkey hosts, 
implicating Vif as a key factor underlying retroviral adaptation. 
The findings presented in this new paper by Compton et al. provide important evidence that SIV 
infection has selected for Vif-resistant forms of A3G in AGMs, even though SIV infection currently 
appears to be generally asymptomatic and nonpathogenic in African green monkeys. In addition to 
shedding light on processes of virus-host adaptation in general, Compton and co-authors provide 
valuable evolutionary context for the development of new HIV therapies that target Vif. 
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Compton et al. (2012) report on a counter-evolutionary ‘arms race’ between A3G 
(produced by African green monkeys and other primates) and Vif, which is 
encoded by human and simian immunodeficiency viruses (HIV and SIVs). The 
authors investigated A3G-Vif interactions using SIV strains collected from four 
African green monkey species, known commonly as the vervet (above), sabaeus, 
tantalus and grivet monkeys (Chlorocebus spp.). 
 
